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Cryotherapy is the commonly used application of a cold compress to alleviate pain and 
swelling with injuries. However, while being one of the more well-known and commonly 
used therapies, there is limited systematic data collected in controlled environments 
showing benefits of cryotherapy. Many claims and perceived benefits of cryotherapy are 
based on empirical and anecdotal evidence, leaving much to be discovered. A typical 
cryotherapy protocol of 30 minutes can suppress blood flow, tissue temperature, and 
present with sustained vasoconstriction in the hours after treatment. This vasoconstriction 
can cause tissue death and necrosis, deemed non-freezing cold injuries, and results in 
roughly ~1,500 reported clinical cases per year in the United States. Furthermore, non-
freezing cold injuries in the civilian population are a rare occurrence, but this type of injury, 
which relates to these investigations can reach epidemic proportions during times of war. 
Our primary findings from the research have implicated Rho kinase as being primarily 
involved in the formation of sustained vasoconstriction following cryotherapy treatment. 
Additionally, Rho kinase action impairs the temperature blood flow relationship that is 
necessary for abolishing much of the risk of ischemic injury.  Secondary findings have 
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furthered our knowledge of mechanisms of locally induced vasoconstriction and the 
significance of the sympathetic nerves in returning blood flow towards basal conditions 
following cryotherapy treatment. Finally, these investigations have shown that there 
appears to be limited involvement of nitric oxide in the lower ranges of blood flow. This 
finding might suggest that during a pronounced vasoconstrictive state (60-80% reduction 
in basal blood flow) much of the action of Rho kinase drives its activity by enhancing 
adrenergic activity. Our findings are generally in agreement with previous literature 
investigating mechanisms of cold-induced vasoconstriction. However, these previous 
studies typically made measurements on much smaller skin surfaces and also used much 
more mild temperatures for cooling. Accordingly, these findings outlined in the current 
studies improve our understanding of the vascular kinetics of cryotherapy use. We 
conclude that there needs to be a greater understanding and awareness provided to layman 
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Chapter 1: Introduction 
Cryotherapy is the use of cold as a therapeutic technique focused on localized 
cooling in attempts to reduce tissue damage, swelling, pain, bleeding, and inflammatory 
processes(84). Many of these benefits lie within the physiological benefit of low tissue 
temperature. Lowering tissue temperature (thermal effect) is considered to be the most 
advantageous benefit of cryotherapy, over the vascular responses, and neural benefits(4, 
65, 85). It is a commonly utilized therapeutic approach to treating an injury or illness and 
is an almost essential follow up to many surgeries, soft tissue injuries, as well as a host of 
other clinical treatments. Cryotherapy application involves locally reducing tissue 
temperature of the affected area through the use of cold water (non-frozen; >0°C) or direct 
ice application. Clinically, there are many advantageous effects of cryotherapy (as outlined 
above), which vastly outweigh the potential deleterious effects. However, while beneficial 
for most individuals, cryotherapy is often associated with a number of negative side effects.  
For example, cryotherapy treatment has been linked to a variety of conditions including, 
tissue necrosis, neuropathy, and in the most extreme cases limb amputation. These 
conditions are likely the result of drastic reductions in local tissue temperature and the 
subsequent pronounced tissue ischemia following the period of cryotherapy, which can 
lead to tissue necrosis and nerve injury. The vasoconstrictive effects of cryotherapy extend 
beyond the treatment phase and persist for hours following the termination of the cooling. 
Injury with cryotherapy is likely, at least in part, attributed to the pronounced local 
vasoconstriction which results in an inability to deliver blood and oxygen to the tissues for 
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a sustained period causing tissue ischemia, necrosis, and death. This ischemia can occur 
due to short (i.e. within 5 min) and prolonged (i.e. 30 min or longer) cryotherapy treatment, 
but also persists during the subsequent recovery phase. Cryotherapy can cause persistent 
vasoconstriction even after the cessation of cooling, which can lead to cell death if oxygen 
delivery is compromised to the tissues for a substantial duration of time. This persistence 
arises from enhanced modulation of the vasoconstrictor tone and inhibition of the 
vasodilatory pathway(s)(87), which have been previously elucidated(13, 32, 42, 45, 51, 56, 
60, 66). Independently these responses aren’t deleterious, however, once tissue rewarms, 
and vasoconstriction persists, profound ischemic stress develops(65). The underlying 
interplay between the two systems is currently not well understood, within in vivo 
models(87). The two pathways are mutually exclusive and each acts to offset or 
counterbalance the effect of the other, but their role, as it pertains to cryotherapy, is not yet 
known. The previous studies investigating the interplay or independent vascular pathways 
during skin surface cooling were highly controlled. While these studies are very 
informative and provide much mechanistic insight into vascular control, from a 
physiologically perspective they used conditions (see below) that likely do not adequately 
represent what occurs during cryotherapy treatment. For example in most research studies, 
the rate, magnitude and duration of cooling are very well controlled; however, these 
conditions do not necessarily reflect conditions imposed during cryotherapy treatment. For 
example the former involves much more rapid and dramatic cooling. Furthermore, these 
studies cooled a substantially smaller area of tissue than what is common during 
cryotherapy treatment (silver dollar vs. entire joints and muscle groups; respectively). 
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Therefore, understanding the role of these antagonistic pathways during a practical 
application such as cryotherapy treatment is necessary, to begin to understand ideal 
protocols for cryotherapy, with as few complications as possible.  
Accordingly, the primary focus of my dissertation research is to investigate several 
candidate mechanisms involved in the control of vascular tone during skin surface cooling. 
This was accomplished by infusing vasoactive substances, via microdialysis, into the skin 
microvasculature. This approach allowed us to investigate the role of various mechanisms 
of vascular control within the skin while undergoing a typical cryotherapy protocol. 
Multiple treatment sites can be generated with the microdialysis technique. By monitoring 
the blood flow over each pharmacologically altered portion of the skin with laser Doppler 
probes, we assessed multiple components of these pathways as it pertains to ischemic 
injury with cryotherapy. With this approach, we investigated specific elements of the 
vasoconstrictor and vasodilator pathways with the focus on returning blood flow to 




Chapter 2: Statement of the Problem 
Cryotherapy is the use of cold as a therapeutic technique focused on localized 
cooling in attempts to reduce tissue damage, swelling, pain, bleeding, and inflammatory 
processes(84). Many of these benefits lie within the physiological responses to reductions 
in tissue temperature. Lowering tissue temperature (thermal effect) is considered to be the 
most advantageous benefit of cryotherapy, over the vascular responses, and neural 
benefits(4, 65, 85). It is a commonly utilized therapeutic approach to treating an injury or 
illness and is almost essential follow up to many surgeries, soft tissue injuries, as well as a 
host of other clinical treatments. Cryotherapy application involves locally reducing tissue 
temperature of the affected area through the use of cold water (non-frozen; >0°C) or direct 
ice application. Clinically, there are many advantageous effects of cryotherapy (as outlined 
above), which vastly outweigh the potential deleterious effects. However, while beneficial 
for most individuals, cryotherapy is often associated with a number of negative side effects.  
For example, cryotherapy treatment has been linked to a variety of conditions including, 
tissue necrosis, neuropathy, and in the most extreme cases limb amputation. These 
conditions are likely the result of drastic reductions in local tissue temperature and the 
subsequent pronounced tissue ischemia following the period of cryotherapy, which can 
lead to tissue necrosis and nerve injury. The vasoconstrictive effects of cryotherapy extend 
beyond the treatment phase and persist for hours following the termination of the cooling. 
Injury with cryotherapy arises from the inability to deliver blood and oxygen to the 
tissues for a sustained period which can result in tissue ischemia, necrosis, and death. This 
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ischemia can occur due to acute and prolonged cryotherapy treatment, but also during the 
subsequent recovery phase. Cryotherapy can cause persistent vasoconstriction even after 
cooling terminates, which can lead to cell death if oxygen delivery is compromised to the 
tissues. This persistence arises from enhanced modulation of the vasoconstrictor tone and 
inhibition of the vasodilatory pathway(s)(87), which have been previously elucidated(13, 
32, 42, 45, 51, 56, 60, 66). Independently these responses aren’t deleterious, however, once 
tissue rewarms, and vasoconstriction persists, profound ischemic stress develops(65). The 
underlying interplay between the two systems is currently not well understood, within in 
vivo models(87). Cryotherapy has a wide range of uses clinically. It is often associated 
with a host of different modalities aimed at utilizing the benefits from cold in treating an 
underlying injury or medical concern. However, as previously mentioned, it is not without 
its potential complications. The purpose of this series of investigations is to understand 
better how cryotherapy can generate secondary ischemic damage within the treatment area 
due to the persistent vasoconstrictor tone. Therefore, in study #1 we investigated one of 
the primary modulators of the vasoconstrictor pathway, Rho kinase, and its role in a 
cryotherapy protocol. Specific contributors of the Rho kinase pathway were teased out, 
pharmacologically, to investigate how this pathway modulates vascular tone while 
recovering from cryotherapy. Blood flow was assessed with laser Doppler flow probes, 
and specific parts of the constrictor pathway blocked utilizing the microdialysis technique 
to infuse drugs, pharmacologically, changing the vascular response. The aim for study #2 
was to identify the role of the adrenergic nervous system on blood flow during cryotherapy 
induced cooling as well as during passive and active rewarming. Due to the clear role that 
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the sympathetic nerves play in systemic vascular vasoconstriction as well on cutaneous 
vasodilation, we investigated the significance of adrenergic function within cryotherapy, 
utilizing the same methods as in study #1. However, following passive rewarming an acute 
active heating phase occurred by perfusing hot water on the treatment site to assess 
subsequent vasoreactivity. We blocked multiple aspects of the sympathetic pathway to 
investigate this issue both pre and post-synaptically. Finally, for the purposes of study #3 
we focused on one of the primary vasodilatory pathways, the nitric oxide pathway. 
Persistent vasoconstriction is thought to downregulate the nitric oxide pathway which, 
therefore, may contribute to the ischemic state independent / or in addition to the actual 
vasoconstrictive effects. The investigation into the role of nitric oxide during cryotherapy 
and recovery is, therefore, essential for returning blood flow to baseline conditions.  
Overall, we used these 3 studies to investigate the role of multiple steps of the two 
antagonistic systems, vasoconstriction, and vasodilation, are regulated as the skin 





Chapter 3: Experimental Design 
Systematic investigations into the mechanisms of vasoconstriction that mediate the 
profound state of vasoconstriction that occurs during cryotherapy requires a 
pharmacological approach. Drug manufacturing has come a long way and allows for 
specific blockade of receptors, pathways, and multiple isoforms of certain receptors, 
enzymes, or molecules, ultimately allowing for a systematic approach to understanding 
many aspects of vascular tone. Additionally, the microdialysis technique is a minimally-
invasive technique able to deliver a drug challenge that can either enhance or inhibit 
pathways and molecular action. An additional advantage to microdialysis is the localized 
effect of these drug challenges, allowing the assessment of multiple drugs on several 
sections of treated skin simultaneously. We, therefore, utilized the microdialysis technique 
while assessing the action of three separate drug challenges with a typical cryotherapy 
protocol and commercially available cryotherapy unit. This protocol design allowed for the 
most translatable model towards either the clinical application of cold or the self-treating 
individuals in their homes. This approach provides us with the greatest chance of furthering 
the knowledge and understanding of cryotherapy treatment as a whole.  
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Chapter 4: Study #1 
ABSTRACT 
Cryotherapy is a therapeutic technique using ice or cold water applied to the skin to reduce 
local blood flow. While beneficial, there are some side effects such as pronounced 
vasoconstriction and tissue ischemia that is sustained for hours post-treatment. For 
example, cryotherapy treatment induces pronounced tissue ischemia that is sustained for 
hours even during a post-treatment rewarming period.   
PURPOSE: To investigate the role of multiple components of the Rho kinase activation 
on cutaneous blood flow during 30 min of cryotherapy as well as during the subsequent 2 
hr of passive rewarming. This study tested the hypothesis that this pronounced and 
sustained vasoconstriction is mediated by 1) Rho-kinase and/or 2) elevated oxidative stress 
and 3) neuropeptide-Y.  
METHODS: 13 subjects were fitted with a commercially available cryotherapy unit with 
a water perfused bladder on the lateral portion of the right calf. Four microdialysis 
membranes were threaded through the dermis of the skin directly underneath the water 
bladder. One site was perfused with lactated ringers solution (CON) which served as the 
control site, one with Fasudil (FAS) to locally block the Rho Kinase pathway, one with 
BIBP (BIBP) to block Neuropeptide Y mediated vasoconstriction, and one with vitamin C 
(VitC) to reduce cold-induced oxidative stress. Skin temperature (SkT) and skin vascular 
conductance (CVC) was measured at each site. Following instrumentation and baseline 
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data collection the subjects were exposed to 0 °C water perfused through the cryotherapy 
bladder for 30 min, followed by passive rewarming (i.e. water shut off) for 2 hr.   
RESULTS: SkT fell from 34°C to 17.9°C during cold water application across all sites. 
CVC was reduced after 30 min of cooling with both FAS and VitC (71 and 53%, 
respectively; p<0.05) having attenuated vasoconstriction when compared to control (43%). 
Following 2 hr of passive rewarming CVC was elevated at the FAS site (69%) whereas it 
remained reduced at the CON and VitC sites (26 and 25%, respectively; p<0.05).  
CONCLUSION: These findings indicate that the Rho-kinase and oxidative stress 
contribute to pronounced vasoconstriction during cryotherapy and that the Rho-kinase 
pathway contributes to sustained vasoconstriction during the subsequent rewarming period 
post treatment 




Cryotherapy application is a widely used therapeutic technique using ice or cold 
water on the skin and is used clinically to reduce local blood flow(17, 86, 94), decrease 
cellular metabolism(74), reduce pain(11), and attenuate edema formation(20). Cryotherapy 
treatment is commonplace therapeutically following surgery or injury to attenuate the 
associated swelling, pain, and damage that can occur within the injured tissue. Of the 
benefits of cryotherapy, the vascular effects are one of the three primary responses to skin 
cooling, which aids in reducing swelling and edema. Several investigators have identified 
the mechanisms of vasoconstriction responsible for this vascular response during 
application of local cooling(6, 7, 51, 72, 97), but still not understood is how these 
mechanisms pertain to cryotherapy treatment in clinical settings.  Investigations into the 
mechanisms of cooling induced vasoconstriction have found the Rho kinase pathway(6) to 
be centrally involved in the cutaneous vasoconstrictor response. It is activated by the 
formation of mitochondrial reactive oxygen species in response to cold within the vascular 
smooth muscle(7) and exists as one of the most powerful modulators of vasoconstriction. 
Rho kinase in response to local skin cooling induces translocation of α2-
adrenoreceptors to the smooth muscle surface and also increases their sensitivity for 
norepinephrine(29, 47, 73, 93), with an additional inhibition of vasodilator pathways(42, 
87). The Rho kinase pathway also downregulates eNOS(87) and thus reduces nitric oxide 
(NO) bioavailability during as well as for up to 2 hr post skin cooling(42). Skin cooling to 
24 ºC presented with a 40% reduction in basal blood flow for two hours, which would 
imply pronounced constrictor tone. These findings make the Rho kinase pathway of 
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primary interest in regards to skin cooling and rewarming due to the changes in the NOS 
pathway and enhanced constrictor tone. In addition, previous studies have determined that 
subcutaneous application of Vitamin C attenuates cold-induced vasoconstriction, 
potentially due to a reduction in reactive oxygen species (ROS) formation in the 
mitochondria impairing Rho kinase activation.  
Cryotherapy treatment typically involves cooling of a much larger skin surface 
area, a greater magnitude of skin cooling, and ultimately a greater depth of cooling within 
the tissue relative to the aforementioned studies that have investigated mechanisms of cold-
induced vasoconstriction (39, 41, 97). Additionally, sustained vasoconstriction to local 
cooling at 24 ºC increases release of norepinephrine and neuropeptide-Y (NPY) from the 
sympathetic nerve terminals. To our knowledge, the relative contribution of NPY to cold-
induced vasoconstriction remains relatively unknown.  
Accordingly, the aim of this study was to investigate the role of neuropeptide-Y, 
Rho kinase, and reactive oxygen species on the vasoconstrictor mechanisms during 
cryotherapy mediated cooling and the subsequent recovery of blood flow with passive 
rewarming. It is currently unknown how a greater magnitude of cooling and colder 
temperature would augment the findings and the post treatment recovery of blood flow 
shown in previous studies. We hypothesized that with the application of microdialysis in 
combination with cryotherapy we can identify that the Rho kinase pathway is a significant 
mediator of vasoconstriction during cryotherapy and sustained vasoconstriction following 
skin cooling with Fasudil treatment. Additionally, we hypothesized that local infusion of 
vitamin C we would be able to attenuate vasoconstriction by interfering with reactive 
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oxygen species formation and the activation of Rho kinase. Finally, with the inhibition of 
neuropeptide-Y we hypothesized that we would attenuate the magnitude of 





Ethical Approval. The Institutional Review Board at The University of Texas at Austin 
approved all study procedures and the consent process used in the present study. Subjects 
were given a verbal description of all procedures and informed of the purpose and risks 
involved in the study before providing their informed and written consent.   
 
Subjects. 12 healthy young subjects (10 males) participated in this study. Average (mean 
± SEM) subject characteristics were: age, 24 ± 1 years; height, 180 ± 1 cm; and weight, 81 
± 3 kg. Subjects were non-smokers, were not taking medications and were free from 
cardiovascular, neurological, or metabolic diseases. None of the subjects reported a history 
of knee injury or cryotherapy or other form of cold exposure in the lower extremities for at 
least a year prior to the experiment. All studies were conducted in the morning following 
an overnight fast (> 12 hr). Subjects refrained from strenuous exercise, alcoholic beverages, 
and caffeine for 24 hrs prior to the experimental trial. Additionally subjects underwent an 
overnight fast for at least 10 hr prior to the experimental trial, which was conducted in a 
temperature controlled laboratory (~24°C and 40% relative humidity).  
 
Instrumentation and Measurements: All data were collected with the subject seated in a 
semi-recumbent position. Four microdialysis membranes (CMA 31 Linear Microdialysis 
Probe, 55 KDalton cut-off membrane; Harvard Apparatus, Holliston, MA) were inserted 
~5 cm apart into the nonglabrous skin on the lateral side of the right calf. Following 
placement, each membrane was perfused with lactated Ringer’s solution (Baxter, 
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Deerfield, IL) at a rate of 2 L/min via a perfusion pump (Harvard Apparatus, Holliston, 
MA) while insertion trauma associated with membrane placement subsided (minimum 90 
min). During this period, each membrane site was instrumented with an integrating laser 
Doppler flow probe (VP7a, Moor Instruments, Wilmington, DE) which provided a 
continuous index of skin blood flow. A thermocouple (Type T Thermocouple Probe, 
Physitemp Instruments INC, Cliffton, NJ) was placed immediately adjacent to the Doppler 
flow probe for the continuous assessment of local skin temperature. Following placement 
of the membranes, Doppler flow probes, thermocouples, and a commercially available 
cryotherapy cooling pad (Arctic Ice Universal Pad; Pain Management Technologies, 
Akron, OH) was applied overlying the instrumented area, and fixed in place using an Ace 
bandage. The cooling pad was connected to an Arctic Ice cryotherapy unit (Pain 
Management Technologies, Akron, OH) which allowed for manipulation of the underlying 
skin (Tskin) and tissue temperature according to the manufacturer’s recommendation (see 
below for more detail). A cuff was placed around the left arm for intermittent blood 
pressure measurements from the brachial artery using electrosphygmomanometry (Tango, 
SunTech Medical Instruments, Raliegh, NC). 
 
Study Protocol: After the hyperemic response associated with insertion trauma subsided 
(minimum of 90 min) each site was perfused with its respective vasoactive agent for a 45 
min wash in period. One site received lactated Ringer solution (CON, Baxter, Deerfield, 
IL) which served as the control site. Inhibition of the Rho Kinase pathway was achieved 
with a 3 mM Fasudil infusion to a second site (FAS, ToCris Bioscience, Ellisville, MO). 
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Inhibition of NPY was achieved through a 10 μM solution of the NPY Y1 antagonist N2- 
(diphenylacetyl)-N-([4-hydroxyphenyl]methyl)-d-arginine amide (BIBP; Sigma, St Louis, 
MO, USA) at a third site and the last site received Ascorbic Acid (Vitamin C) (VitC, 
10mM, Mylan Institutional LLC, Rockford, IL) to locally scavenge reactive oxygen 
species. Fasudil, BIBP and Ascorbic Acid were dissolved in sterile lactated Ringer 
solution. Each site was initially perfused at 52 L/min for a 30 sec priming period after 
which the rate was reduced to 2 L/min for the remainder of data collection. Following 
instrumentation the cooling pad was perfused with 34 ºC water for the entire hyperemic 
and drug infusion period for baseline data collection. This was followed by 30 min of active 
skin-surface cooling that was accomplished by circulating 0 - 1 ºC water through the 
cryotherapy unit and cooling pad. At the end of the cooling phase the cryotherapy unit was 
turned off for a 2 hr period of data collection during passive rewarming and disconnected 
from the cold water reservoir.   
 
Data Analysis: Laser-Doppler flux and Tskin data was continuously collected at a 
sampling rate of 125 Hz via a data-acquisition system (Biopac System, Santa Barbara, CA). 
One min averages of these data were analyzed at the following time points: the final min 
of the 34 ºC baseline condition (baseline), min 5, 10, 15, 20, 25, and 30 of active cooling; 
and min 30, 60, 90, and 120 of passive rewarming. Mean arterial pressure (MAP) was 
calculated as 1/3 systolic pressure + 2/3 diastolic pressure and used for subsequent 
calculation of cutaneous vascular conductance (CVC) (Doppler-derived flux/MAP). All 
CVC data throughout active cooling and passive rewarming were normalized to value 
 
 16
obtained during the final min of 34 ºC baseline and expressed as %CVC. Hysteresis loops 
were created by comparing the temperature and %CVC relationship for each of the 
different drug treatments. The slope for cooling and passive rewarming was separately 
measured between treatments for comparison. 
 
Statistical Analysis: Statistical analyses were performed using a statistical software 
package (SigmaPlot 12.5; Systat Software, Inc., San Jose, CA). Skin blood flow, %CVC, 
and skin temperature, Tskin, were both analyzed using separate two-way repeated 
measures ANOVAs comparing the control site to the other sites (i.e. CON vs. FAS; CON 
vs. VitC; and CON vs. BIBP) by time effects. When a main effect or interaction was found, 
a Tukey's posthoc analysis was performed to determine further differences. All data is 





Throughout the active cooling period Tskin decreased at all sites relative to the pre-
cooling baseline. Average temps at the sites were; Baseline: 34±0.2 vs. Cooling: 26.9±1.2, 
24.1±1.2, 21.3±1.2, 20.1±1.1, 18.6±1.1, 17.9±1.1, °C; 5, 10, 15, 20, 25, 30 min cooling, 
respectively; p=0.001) and recovered towards baseline with passive rewarming (30, 60, 
120-min Rewarming: 23.6±0.4, 25.3±0.3, 27.5±0.3 °C, respectively; p=0.001), but still had 
not reached baseline levels even after 2 hrs of rewarming (Fig. 1a).  Tskin were no different 
among the 4 trials at any time point (p>0.05). 
Skin vascular conductance, %CVC, during the ~34°C baseline and throughout the 
cooling and reheating protocol is illustrated in Figure 1b. Local cold water application 
resulted in a significant decrease from baseline %CVC in all trials (p<0.001). During active 
skin-cooling CVC was reduced to a greater magnitude at the CON site relative to the VitC 
site (43±5 vs. 53±9 % of baseline, respectively; p =0.027) and FAS site ( 43±5 vs. 71±14 
% of baseline, respectively; p =0.001); however, the reduction at the CON and BIBP sites 
were similar ( 43±5 vs. 44±24 % of baseline, respectively; p>0.05) (Fig. 1b). During 
passive rewarming, CVC at the control site was reduced relative to the FAS site (27±7 vs. 
69±13 % of baseline, respectively; p=0.001), but CVC at the CON site was similar to both 
the VitC site and the BIBP site (26±5 vs. 25±3 vs. 25±12 % of baseline, respectively; 
p>0.05). In fact in these three sites CVC was reduced 2 hr post-cooling to a similar degree 
as at the end of 30 min skin-surface cooling (CON: 30-min Cooling: 29±2 vs. Rewarming 
@ 30, 60, 120: 21±3, 23±2, 35±6 % of baseline, respectively; p=0.86) (VitC: 30-min 
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Cooling: 36±4 vs. Rewarming @ 30, 60, 120: 23±2, 24±2, 30±2 % of baseline, 
respectively; p=0.89) 
Hysteresis loops were broken down into cooling and passive rewarming. There was 
a significant difference between slopes during the cooling phase (CON: 4.16±0.3, VitC: 
4.16±0.3, BIBP: 3.53±0.6, FAS: 2.7±0.3 %CVC/°C; p<0.048), and during passive 
rewarming (CON: 1.33±0.5, VitC: -0.12±0.5, BIBP: -0.44±1.1, FAS: 3.09±1.2 %CVC/°C; 
p=0.036), with posthoc analysis showing FAS being significantly different from BIBP 
(p=0.044) (Fig. 2). When all data was run as a two-way ANOVA (treatment vs. 
cooling/passive rewarming) there was a no significant effect of treatment (p=0.32), but 
there was an effect of cooling/passive rewarming (p<0.01) and a significant interaction 
between treatment and cooling/passive rewarming (p<0.01). Post hoc analysis shows that 
within each treatment there was a significant difference between their respective cooling 
and passive rewarming phases (CON: 3.53±0.6 vs. -0.44±1.1; p<0.01; VitC: 4.16±0.3 vs. 
-0.12±0.5; p < 0.01; BIBP: 4.16±0.3 vs. 1.3±0.5 %CVC/°C; p<0.01), except in the case of 





Our primary finding is that the pronounced vasoconstriction that occurs during 30 
min of skin-surface cooling and the sustained vasoconstriction that persists in the 
subsequent 2 hr passive rewarming period was significantly blunted when the Rho Kinase 
pathway is blocked. Additionally, vasoconstriction during skin-surface cooling was 
blunted following antioxidant supplementation; however this treatment did not have an 
effect on the sustained vasoconstriction during passive rewarming. Contrary to our 
hypothesis blockade of NPY receptors had no effect on vasoconstriction during either the 
cooling or rewarming periods. Together these data suggest a disconnect between skin 
temperature and blood flow during rewarming, and a unique role for ROS and the Rho 
kinase pathway in the vasoconstrictor response during and after cryotherapy application 
(Fig 2).  
Our data agrees with findings that suggest local cooling mediated vasoconstriction 
is directly impacted by Rho kinase(6). Fasudil treatment inhibited the Rho kinase pathway 
and was responsible for roughly 40% of the total vasoconstrictor response over CON. 
Thompson-Torgerson et al. performed a similar protocol by cooling skin from 34-24°C and 
showed a similar response by inhibiting the Rho kinase pathway while control sites fell 
77% (88). We experienced a greater degree of vasoconstriction while infusing Fasudil 
despite a similar level of vasoconstriction in the control site, which could be attributed to 
the magnitude of skin cooling, the rate of cooling, and the application of an ice slurry (0-
1°C)  rather than a small surface cooling elements (24°C) or suggest a larger contribution 
of local adrenergic mechanisms with our protocol(88). 
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 Since the production of mitochondrial ROS has been proposed as a critical step in 
the signaling mechanism for vasoconstriction, we chose to investigate this mechanism 
during cryotherapy. Other studies have shown that vitamin C application with 
microdialysis attenuates vasoconstriction when using smaller skin surface cooling devices 
and cooling to 24°C(97).  Despite these minor differences in cooling protocol, our results 
support a similar attenuation in the rate of vasoconstriction with vitamin C. However, as 
vitamin C was not able to fully attenuate the vasoconstrictor response and formation of 
Rho kinase we believe this data suggests incomplete blockade. This is based on the fact 
that the VitC and FAS treatments were significantly different. One shortcoming with the 
use of vitamin C it is non-specific once introduced, and may require a more specific anti-
oxidant to abolish the ROS formation within the mitochondria.  
Statistically, there is little to be said about the hysteresis loops as the posthoc 
analysis was not able to show any differences between treatments. However, Fasudil 
treatment was the only treatment to show a similar temperature to blood flow relationship 
between cooling and passive rewarming. This suggests that the inability of the cold 
vasoconstricted tissue to return towards basal levels of blood flow is primarily a function 
of Rho kinase. This is the strongest evidence towards Rho kinase mediating the sustained 
vasoconstriction due to the similar rate of cooling and rewarming with Fasudil treatment. 
Some experimental considerations to take into account are that the 3 mM fasudil 
used in this study may not have fully blocked the Rho kinase pathway. At larger doses, 
fasudil starts to have significant action on multiple kinases also responsible for 
vasoconstriction, but not the Rho kinase pathway(88). Previous studies have shown a high 
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degree of blockade with 3 mM. However, our study utilized a larger magnitude of cooling 
limiting the comparability between studies. Additionally, since the application of Y27632 
is currently not FDA approved fasudil remains the only complete inhibitor of the Rho 
kinase pathway FDA approved for human use. 
In summary, fasudil treatment and inhibition of Rho kinase explains a large portion 
of the vasoconstrictor tone that occurs during and following a typical cryotherapy protocol. 
This conclusion is supported by both previous and present findings that fasudil mediates a 
large portion of the vasoconstrictor response to local cooling. The results of this study also 
implicate Rho kinase as the mediator of sustained and pronounced vasoconstriction and 





TABLES AND FIGURES 
Figure 1. Temperature and blood flow responses to cryotherapy and the subsequent 
recovery 
 
Figure 1. - Panel A) Skin temperature during a typical cryotherapy protocol and the 
subsequent 2-hour recovery. * denotes significantly different than baseline p<0.01. ** 
denotes significantly different than the end of the 30 min cryotherapy period p<0.01. Panel 
B) † denotes significantly different than baseline %CVC p<0.01. ‡ denotes FAS was 
statistically different from CON, VitC, and BIBP p<0.01.  
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Figure 2. Hysteresis loops during cryotherapy treatment and the subsequent recovery 
 
Figure 2 – Panel D) was found to have a significantly  different slope to active cooling 
when compared to CON, VitC, and BIBP. Additionally, in panels A, B, and C each 
treatment was found to have a significantly different slope for cooling and passive 
rewarming, but not for FAS (Panel D).  
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Chapter 5: Study #2 
ABSTRACT 
Cryotherapy application is a widely clinically used therapeutic technique using ice or cold 
water applied to the skin surface to reduce local blood flow. While beneficial, cryotherapy 
treatment does have the potential to induce some detrimental physiological side effects. 
For example, cryotherapy treatment induces pronounced tissue ischemia that is sustained 
for hours even during a post-treatment rewarming period.   
PURPOSE: To investigate the role of adrenergic receptor activation on cutaneous blood 
flow during 30 min of cryotherapy as well as during the subsequent 1 hr of passive 
rewarming. We hypothesized that adrenergic-mediated vasoconstriction is involved in 
pronounced and sustained cutaneous vasoconstriction that occurs during cooling and 
passive rewarming. 
METHODS: A commercially available cryotherapy unit with a water perfused bladder 
was used. The bladder was placed on the lateral portion of the calf. Four microdialysis 
membranes were threaded through the dermis of the skin directly underneath the water 
bladder. One site was perfused with lactated ringers solution (CON), one with bretylium 
tosylate (PRE) to block the presynaptic release of neurotransmitters from the sympathetic 
nerve terminals, one with propranolol+yohimbine+BIBP (POST) to block the postsynaptic 
beta-adrenoreceptors, alpha-receptors, and neuropeptide Y receptors, and one with 
propranolol+BIBP (P+B), to block the postsynaptic beta-adrenoreceptors, and 
neuropeptide Y receptors. Skin temperature (SkT) and skin vascular conductance (CVC) 
 
 25
was measured at each site. Subjects had 0 °C water perfused through the cryotherapy 
bladder for 30 min, followed by passive rewarming (i.e. water shut off) for 1 hr, followed 
by direct heating with 46 °C for 10 min.   
RESULTS: SkT fell from 34°C to 18.8°C during 30 min of cold water application across 
all sites. CVC at CON was reduced to 26% of baseline at the end of 30 min of cooling and 
was not significantly different from P+B (p>0.05). Skin CVC decrease across 30 min of 
cryotherapy was attenuated at the PRE and POST sites while cooling (5-30min) compared 
the control (CVC: BRE = 65%, POST = 62%, CON 41% of baseline (p<0.05 for each 
comparison)). The CVC response to 10 min of active warming and the 20 min following 
was lower in PRE site than CON and POST (CVC: 39% vs. 52% and 52%, respectively; 
(p<0.05). CONCLUSION: Our primary finding was that adrenergic function mediates the 
withdrawal of vasoconstriction that occurs with active heating following a cryotherapy 
protocol. This is in line with previous literature investigating the adrenergic mechanisms 
of vasoconstriction with skin cooling. 




We have previously reported a significant role of the Rho kinase pathway in the 
pronounced vasoconstriction that occurs during skin surface cooling as well as the 
sustained vasoconstriction that occurs following cessation of skin-surface cooling. One of 
the mechanisms of Rho kinase is the elevated activity of the α2C adrenoceptor density and 
sensitivity(34-38). This activity would enhance the other local vasoconstrictor pathway 
driven by the short local loop sympathetic neurons. Investigation of the potential 
contributions of the local adrenergic sympathetic nervous system is, therefore, significant 
especially with the possible action of neuropeptide-Y and heightened sensitivity to 
norepinephrine.  
Findings by other investigators have illustrated that the local adrenergic activity 
explains ~95% of the vasoconstrictor tone on the skin, but with mild skin cooling(34-31 
ºC)(51). As local skin temperature starts to dip lower, the adrenergic vasoconstrictor tone 
becomes less significant, and vasoconstriction is driven by Rho kinase(59, 88). No study 
has fully investigated the activity of the adrenergic action to local cooling or the 
temperatures reached during typical cryotherapy protocol.  
Due to Rho kinase activity causing increased α2C adrenoceptor density and 
sensitivity we believe it plays a significant role in triggering the sustained vasoconstriction 
that occurs due to local cooling. We hypothesized that the local adrenergic sympathetic 
neurons would be principally involved in the sustained vasoconstriction that occurs after 
skin cooling. Finally, we hypothesized by comparing pre-synaptic and post-synaptic 




Ethical Approval. The Institutional Review Board at The University of Texas at Austin 
approved all study procedures and the consent process used in the present study. Subjects 
were given a verbal description of all procedures and informed of the purpose and risks 
involved in the study before providing their informed, written consent.   
 
Subjects. 9 healthy young subjects (6 males) participated in this study. Average (mean ± 
SEM) subject characteristics were: age, 27 ± 2 years; height, 178 ± 1 cm; and weight, 77 ± 
3 kg. Subjects were non-smokers, were not taking medications and were free from 
cardiovascular, neurological, or metabolic diseases. None of the subjects reported a history 
of knee injury or cryotherapy or other form of cold exposure in the lower extremities for at 
least a year prior to the experiment. All studies were conducted in the morning following 
an overnight fast (> 12 hr). Subjects refrained from strenuous exercise, alcoholic beverages, 
and caffeine for 24 hrs prior to the experimental trial. Additionally subjects underwent an 
overnight fast for at least 10 hr prior to the experimental trial, which was conducted in a 
temperature controlled laboratory (~24°C and 40% relative humidity).  
 
Instrumentation and Measurements: All data were collected with the subject seated in a 
semi-recumbent position. Four microdialysis membranes (CMA 31 Linear Microdialysis 
Probe, 55 KDalton cut-off membrane; Harvard Apparatus, Holliston, MA) were inserted 
~5 cm apart into the nonglabrous skin on the lateral side of the right calf. Following 
placement, each membrane was perfused with lactated Ringer’s solution (Baxter, 
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Deerfield, IL) at a rate of 2 L/min via a perfusion pump (Harvard Apparatus, Holliston, 
MA) while insertion trauma associated with membrane placement subsided (minimum 90 
min). During this period, each membrane site was instrumented with an integrating laser 
Doppler flow probe (VP7a, Moor Instruments, Wilmington, DE) which provided a 
continuous index of skin blood flow. A thermocouple (Type T Thermocouple Probe, 
Physitemp Instruments INC, Cliffton, NJ) was placed immediately adjacent to the Doppler 
flow probe for the continuous assessment of local skin temperature. Following placement 
of the membranes, Doppler flow probes, thermocouples, and a commercially available 
cryotherapy cooling pad (Arctic Ice Universal Pad; Pain Management Technologies, 
Akron, OH) was applied overlying the instrumented area, and fixed in place using an Ace 
bandage. The cooling pad was connected to an Arctic Ice cryotherapy unit (Pain 
Management Technologies, Akron, OH) which allowed for manipulation of the underlying 
skin (Tskin) and tissue temperature according to the manufacturer’s recommendation (see 
below for more detail). A cuff was placed around the left arm for intermittent blood 
pressure measurements from the brachial artery using electrosphygmomanometry (Tango, 
SunTech Medical Instruments, Raliegh, NC). 
 
Study Protocol: After the hyperemic response associated with insertion trauma subsided 
(minimum of 90 min) each site was perfused with its respective vasoactive agent for a 90 
min wash in period. One site received lactated Ringer solution (CON, Baxter, Deerfield, 
IL) which served as the control site. Postsynaptic receptor blockade was achieved at one 
site, which received 1 mM propanolol, 5mM yohimbine, 10 mM BIBP (POST). 
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Presynaptic blockade of neurotransmitter release from the sympathetic nerve terminal was 
achieved with a treatment at a third site with 10 mM bretylium tosylate (PRE). Isolation of 
the role of α receptors was achieved with infusions of a mixture of 1 mM propranolol and 
10 mM BIBP (P+B) to block postsynaptic beta-adrenoreceptors and NPY receptors 
respectively. All drugs were obtained from Sigma-Aldrich (St Louis, MO, USA). All 
solutions were dissolved in sterile lactated Ringer solution. Each site was initially perfused 
at 52 L/min for a 30 sec priming period after which the rate was reduced to 2 L/min for 
the remainder of data collection. Following instrumentation the cooling pad was perfused 
with 34 ºC water for the entire hyperemic and drug infusion period for baseline data 
collection. This was followed by 30 min of active skin surface cooling that was 
accomplished by circulating 0 - 1 ºC water through the cryotherapy unit and cooling pad. 
At the end of the cooling phase, the cryotherapy unit was turned off for a 1 hr period of 
data collection during passive rewarming and disconnected from the cold water reservoir. 
Following passive rewarming for 1 hr a brief, 10 min, active heating phase takes place by 
perfusing 46 ºC water through the cryotherapy pad. After this 10 min heating period, the 
pump was turned off again, disconnected from the hot water reservoir for a  final 20 min 
period of passive rewarming. 
 
Data Analysis: Laser-Doppler flux and Tskin data were continuously collected at a 
sampling rate of 125 Hz via a data-acquisition system (Biopac System, Santa Barbara, CA). 
One min averages of these data were analyzed at the following time points: the final min 
of the 34 ºC baseline condition (baseline), min 5, 10, 15, 20, 25, and 30 of active cooling; 
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min 30, 60, of passive rewarming; min 10 active rewarming; and 10 and 20 minutes post 
active heating. Mean arterial pressure (MAP) was calculated as 1/3 systolic pressure + 2/3 
diastolic pressure and used for subsequent calculation of cutaneous vascular conductance 
(CVC) (Doppler-derived flux/MAP). All CVC data throughout active cooling and passive 
rewarming were normalized to value obtained during the final min of 34 ºC baseline and 
expressed as %CVC. Hysteresis loops were created by comparing the temperature and 
%CVC relationship for each of the different drug treatments. The slope for cooling and 
passive rewarming was separately measured between treatments for comparison. 
 
 
Statistical Analysis: Statistical analyzes were performed using a statistical software 
package (SigmaPlot 12.5; Systat Software, Inc., San Jose, CA). Skin blood flow, %CVC, 
and skin temperature, Tskin, were both analyzed using a two-way repeated measures 
ANOVA comparing treatment (CON vs. POST vs. PRE vs. P+B) by time effects. When a 
main effect or interaction was found, a Tukey's posthoc analysis was performed to 
determine further differences. All data is shown as mean±SEM. For all tests, significance 






Skin temperature throughout the trial is shown in fig 3a and decreased with skin 
cooling from baseline due to skin cooling. Average temps at the sites were; Baseline: 
33.8±0.2 vs. Cooling: 28.5±0.5, 24.7±0.3, 22.4±0.3, 20.6±0.3, 19.5±0.3, 18.5±0.3 °C; 5, 
10, 15, 20, 25, 30 min cooling, respectively; p<0.001) and recovered towards baseline with 
passive rewarming when compared to 30 min cooling (30 and 60 Rewarming: 22.4±0.2, 
24.2±0.2 °C, respectively; p=0.001), but still had not reached baseline levels even after 1 
hr of rewarming. Skin temperature increased from 60 min passive rewarming and remained 
elevated in the 10 and 20 minutes in response to active warming (31.6±0.5, 31.2±0.3, 
30.8±4 °C, respectively; p<0.001). Skin temperatures were no different among the 4 
treatments at any time point (p>0.05). 
There was no effect of drug treatment during the 34 baseline for CON, PRE, or 
Y+B (p>0.05), however, POST was significantly higher than its predrug baseline (76±3 
vs. 100±0 %, respectively; p<0.03). Skin blood flow during the ~34°C baseline and 
throughout the cooling and reheating protocol is illustrated in Figure 3b. Local cold water 
application resulted in a significant decrease from baseline %CVC in all trials (p<0.001). 
The reduction in the CON and P+B sites were significantly greater than both POST and 
PRE sites (41±4, 46±4 vs. 65±3, 62±4 % of baseline, respectively; p<0.001) in the 30 min 
while cooling. During the passive rewarming period all treatments were not found to be 
significantly different across time or between treatments (Con: 24±5, POST: 35±5, PRE: 
27±4, Y+B: 30±5 % of baseline; p=0.27). Active heating significantly increased %CVC 
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over the passive recovery phase for all treatments and in the 20 minutes following (60 min 
passive: 27±4 vs. 10 min active heating: 61±6, 10 min post active heating: 66±6, 20 min 
post active heating: 61±5 % of baseline; p<0.001). Additionally, PRE was found to be 
significantly lower than CON, POST, and Y+B in response to active heating and the 20 
minutes following (42±5 vs. 61±4, 56±6, 58±7 % of baseline, respectively; p<0.05) as 
determined by posthoc analysis. 
Hysteresis loops were broken down into cooling, and passive rewarming, and then 








 Our primary finding is that the adrenergic vasoconstrictor nerves in the cutaneous 
circulation partially contributes to the vasodilatory response of cold vasoconstricted skin 
back towards basal blood flow values. Specifically, comparing the responses between 
PRE and POST to active rewarming it appears that there may be cotransmission of an 
additional neurotransmitter from the sympathetic vasoconstrictor nerves that is 
sensitizing tissue to temperature by withdrawing the a portion of the vasoconstrictor tone 
or dilation. 
To our knowledge, this is the first investigation to show that the adrenergic 
vasoconstrictor nerves are involved in the vasodilation of chronically vasoconstricted 
skin. Previous investigations by Hodges et al. had shown that by the co-treatment with 
bretylium and L-NAME abolished all vasodilatory responses to local rewarming when 
heating locally cooled and chronically vasoconstricted skin(42). Based on our finding 
here that roughly 40% of the vasodilatory response to active rewarming is masked by the 
effects of bretylium we would hypothesize that this is mediated by a vasodilator 
neurotransmitter, perhaps stimulating NO, but its release is blocked. However, it is not 
quite fully understood to us what may be occurring within the sympathetic 
vasoconstrictor nerves that facilitate part of this response. Hodges et al. in a separate set 
of studies has shown that by treating the skin with bretylium and rapidly heating the skin 
you can attenuate the early phase vasodilatory action that occurs in the skin suggesting 
some role for the vasoconstrictor nerves in facilitating vasodilation(42). However, this 
finding partially conflicts with other studies that show inhibition of the vasoconstrictor 
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nerves with bretylium does not alter vasodilatory responses to local heating(72). This 
may be due to the fact that this study made its comparisons based on the percentage of 
max CVC rather than percent of baseline, the rate of cooling and max temperature 
attained. 
 Many of our other findings are in support of previous literature on the role of the 
adrenergic vasoconstrictor responses to cooling. We were able to show similar levels of 
vasoconstriction between both pre and post synaptic blockades(51), suggesting 
appropriate blockade of the vasoconstrictor response. However, we experienced a larger 
decrease in blood flow with bretylium treatment than Johnson et al. who showed less than 
10% decrease after 30 min versus our 70% decrease(51). Much of this is due to the nature 
of their model, which utilizes mild skin cooling rather than our much more dramatic 
localized cooling. Local cooling from 34-24°C with bretylium treatment shows a 40% 
decrease in blood flow, which is still 30% higher than the control. When compared to our 
data where at the end of 30 min of cryotherapy POST and PRE were nonsignificantly 
different from CON it would appear that adrenergic activity ceases between skin 
temperature of 24 and 18°C. However, this may require direct measurement of neural 
activity to confirm fully. It appears that as skin temperature is depressed more severely 
the contribution of vasoconstriction shifts towards being more dependent upon Rho 
kinase and less so upon adrenergic regulation, which is supported by the smaller effect of 
bretylium treatment as cooling becomes more dramatic.  
 Of additional mention is that despite any type of drug treatment there was no 
recovery of blood flow during the passive rewarming phase. This is consistent with our 
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previous investigation that showed the only mediation of the passive recovery phase 
came from active Rho kinase inhibition.  Additionally, local skin cooling studies have 
previously mentioned that Rho kinase makes up roughly 60% of the local vasoconstrictor 
tone, but based on this and our previous investigation I would surmise that dropping skin 
temperature below 20 ºC becomes predominantly driven by the Rho kinase pathway, but 
this would require a separate investigation to support adequately. 
 Some experimental considerations are that in this study we infused bretylium 
throughout the entire protocol. While this doesn’t directly impose an issue with our 
findings, it does contrast to some of the literature that primarily pre-treated with 
bretylium and infused saline throughout the remainder of the trail(42). Additionally, 
analysis of our hysteresis loops lacked significance, which may have suffered from a 
limited number of data points during the passive cooling phase.  
 In summary, we have shown that the adrenergic vasoconstrictor nerves are 
involved in returning blood flow towards baseline in chronically vasoconstricted skin. 
This may suggest a role for withdrawal of vasoconstrictor tone or a dilatory response. 
Additionally, we’ve shown that the most appropriate method of restoring the 
temperature-blood flow relationship and abolishing the effects of sustained 




TABLES AND FIGURES 
Figure 3. Skin temperature and blood flow responses to cryotherapy and the subsequent 
passive and active recovery 
 
Figure 3 - Panel A) Skin temperature during a typical cryotherapy protocol and the 
subsequent 1 hour recovery, 10 min active heating and 20 min recovery. * denotes 
significantly different than baseline p<0.01. ** denotes significantly different than the 
end of the 60 min passive recovery period p<0.01. Panel B) † denotes significantly 
different than baseline %CVC p<0.01. ‡ denotes PRE had a statistically different 




Figure 4. Hysteresis loops during cryotherapy treatment and the subsequent recovery 
 
Figure 4 - Hysteresis loops for the adrenergic assessment of the blood flow/temperature 
relationship. No significant effects were found between treatments or across time. 
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Chapter 6: Study #3 
ABSTRACT 
Cryotherapy application utilizes rapid skin cooling to reduce the local blood flow response 
and can manifest with sustained and pronounced vasoconstriction. This vasoconstriction is 
mediated by Rho kinase that has known mechanisms to downregulate and impair nitric 
oxide function in the skin. 
PURPOSE: To investigate the role of nitric oxide on cutaneous blood flow during 30 min 
of cryotherapy as well as during the subsequent 1 hr of passive rewarming. We 
hypothesized that a reduction in nitric oxide bioavailability is involved in the pronounced 
and sustained cutaneous vasoconstriction that occurs during cooling and passive 
rewarming in a typical cryotherapy protocol. 
METHODS: A commercially available cryotherapy unit with a water perfused bladder 
was used. The bladder was placed on the lateral portion of the calf. Four microdialysis 
membranes were threaded through the dermis of the skin directly underneath the water 
bladder. One site was perfused with lactated ringers solution (CON), one with L-NAME, 
one with NPLA, and one with LNIO. Skin temperature (SkT) and skin vascular 
conductance (CVC) was measured at each site. Subjects had 0 °C water perfused through 
the cryotherapy bladder for 30 min, followed by passive rewarming (i.e. water shut off) for 
1 hr, followed by direct heating with 46 °C for 10 min.   
RESULTS: SkT fell from 34°C to 18.7°C during 30 min of cold water application across 
all sites. CVC at CON was reduced ~75% after 30 min of cooling and was not significantly 
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different from LNAME, NPLA, or LNIO (78, 75, 77%, respectively; p>0.05). The CVC 
response to 10 min of active warming and the 10 min following was no different between 
CON and LNAME, NPLA, or NLIO (CVC: 38% vs. 35%, 33%, 32%, respectively; 
(p<0.05). CONCLUSION: Our primary finding was that nitric oxide is not involved in 
the vasoconstrictor response or recovery of blood flow during a typical cryotherapy 
application or active heating. Additionally, our data suggests that active heating of 






The Rho-kinase pathway is a potent mediator of vasoconstriction in the skin in 
response to local cooling. Rho kinase enhances vasoconstrictor tone in part by the down-
regulation of nitric oxide synthase (NOS)(70, 79), which is involved in the formation of 
nitric oxide (NO) and vasodilation. The Rho-kinase and NOS pathways mediating 
vasoconstriction and vasodilation, are mutually inhibitory; cGMP-dependent protein 
kinase (PKG), involved in NO production, inhibits Rho-kinase activation, and Rho-
kinase mediates phosphorylation of MLCP and Rho-kinase can downregulate endothelial 
NOS (eNOS)(70, 79). This interplay between the two pathways is only partially 
understood, but it is likely significant as it pertains to cryotherapy treatment. 
As NO is a primary contributor to local heating induced vasodilation(68) and 
partially contributes to the vasoconstrictor response that occurs to local cooling(42), we 
believe it may contribute to sustained vasoconstriction as well. Additionally, it has 
previously been identified that eNOS specifically contributes to this dilatory response to 
local cooling(55) but has had some conflicting results suggesting nNOS activity within 
the leg of individuals with postural orthostatic tachycardia syndrome(82). 
Therefore, this study examined the role of NO production by the various isoforms 
of  NOS on the vasoconstrictor response during a typical cryotherapy protocol and during 
the sustained vasoconstriction that occurs during the subsequent period of passive 
rewarming. We hypothesized that NOS inhibition would mediate the vasoconstrictor 
response and active rewarming phase. Additionally, we hypothesized that the effects of 




Ethical Approval. The Institutional Review Board at The University of Texas at Austin 
approved all study procedures and the consent process used in the present study. Subjects 
were given a verbal description of all procedures and informed of the purpose and risks 
involved in the study before providing their informed, written consent.   
 
Subjects. 8 healthy young subjects (6 males) participated in this study. Average (mean ± 
SEM) subject characteristics were: age, 25 ± 1 years; height, 179 ± 1 cm; and weight, 79 ± 
2 kg. Subjects were non-smokers, were not taking medications and were free from 
cardiovascular, neurological, or metabolic diseases. None of the subjects reported a history 
of knee injury or cryotherapy or other form of cold exposure in the lower extremities for at 
least a year prior to the experiment. All studies were conducted in the morning following 
an overnight fast (> 12 hrs). Subjects refrained from strenuous exercise, alcoholic 
beverages, and caffeine for 24 hrs prior to the experimental trial. Additionally subjects 
underwent an overnight fast for at least 10 hrs prior to the experimental trial, which was 
conducted in a temperature controlled laboratory (~24°C and 40% relative humidity).   
 
Instrumentation and Measurements: All data were collected with the subject seated in a 
semi-recumbent position. Four microdialysis membranes (CMA 31 Linear Microdialysis 
Probe, 55 KDalton cut-off membrane; Harvard Apparatus, Holliston, MA) were inserted 
~5 cm apart into the nonglabrous skin on the lateral side of the right calf. Following 
placement, each membrane was perfused with lactated Ringer’s solution (Baxter, 
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Deerfield, IL) at a rate of 2 L/min via a perfusion pump (Harvard Apparatus, Holliston, 
MA) while insertion trauma associated with membrane placement subsided (minimum 90 
min). During this period, each membrane site was instrumented with an integrating laser 
Doppler flow probe (VP7a, Moor Instruments, Wilmington, DE) which provided a 
continuous index of skin blood flow. A thermocouple (Type T Thermocouple Probe, 
Physitemp Instruments INC, Cliffton, NJ) was placed immediately adjacent to the Doppler 
flow probe for the continuous assessment of local skin temperature. Following placement 
of the membranes, Doppler flow probes, thermocouples, and a commercially available 
cryotherapy cooling pad (Arctic Ice Universal Pad; Pain Management Technologies, 
Akron, OH) was applied overlying the instrumented area, and fixed in place using an Ace 
bandage. The cooling pad was connected to an Arctic Ice cryotherapy unit (Pain 
Management Technologies, Akron, OH) which allowed for manipulation of the underlying 
skin (Tskin) and tissue temperature according to the manufacturer’s recommendation (see 
below for more detail). A cuff was placed around the left arm for intermittent blood 
pressure measurements from the brachial artery using electrosphygmomanometry (Tango, 
SunTech Medical Instruments, Raliegh, NC). 
 
Study Protocol: After the hyperemic response associated with insertion trauma subsided 
(minimum of 90 min) each site was perfused with its respective vasoactive agent for a 50 
min wash in period. One site received lactated Ringer solution (Baxter, Deerfield, IL) 
which served as the control site (CON), one site received 5mM N5-
[Imino(propylamino)methyl]-L-ornithine hydrochloride (NPLA, blockade of nNOS, 
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Tocris Cookson, Bristol, U.K.), one site received 10 mM N5-(1-Iminoethyl)-L-ornithine 
dihydrochloride (NLIO, blockade of eNOS, Tocris Cookson, Bristol, U.K.), and the last 
received 20 mM Nω-Nitro-L-arginine methyl ester hydrochloride (LNAME, NOS 
blockade, St Louis, MO, USA). All solutions were dissolved in sterile lactated Ringer 
solution. Each site was initially perfused at 52 L/min for a 30 sec priming period after 
which the rate was reduced to 2 L/min for the remainder of data collection. Following 
instrumentation the cooling pad was perfused with 34 ºC water for the entire hyperemic 
and drug infusion period for baseline data collection. This was followed by 30 min of active 
skin surface cooling that was accomplished by circulating 0 - 1 ºC water through the 
cryotherapy unit and cooling pad. At the end of the cooling phase, the cryotherapy unit was 
turned off for a 1 hr period of data collection during passive rewarming and disconnected 
from the cold water reservoir. Following passive rewarming for 1 hr a brief, 10 min, active 
heating phase takes place by perfusing through the cryotherapy pad 46 ºC water. After this 
10 min heating period, the pump was turned off again, disconnected from the hot water 
reservoir for the final 20 min passive rewarming period. 
 
Data Analysis: Laser-Doppler flux and Tskin data were continuously collected at a 
sampling rate of 125 Hz via a data-acquisition system (Biopac System, Santa Barbara, CA). 
One min averages of these data were analyzed at the following time points: the final min 
of the 34 ºC baseline condition (baseline), min 5, 10, 15, 20, 25, and 30 of active cooling; 
min 30, 60, of passive rewarming; min 10 active rewarming; and 10 and 20 minutes post 
active heating. Mean arterial pressure (MAP) was calculated as 1/3 systolic pressure + 2/3 
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diastolic pressure and used for subsequent calculation of cutaneous vascular conductance 
(CVC) (Doppler-derived flux/MAP). All CVC data throughout active cooling and passive 
rewarming were normalized to value obtained during the final min of 34 ºC baseline and 
expressed as %CVC. Hysteresis loops were created by comparing the temperature and 
%CVC relationship for each of the different drug treatments. The slope for cooling and 
passive rewarming was separately measured between treatments for comparison. 
 
 
Statistical Analysis: Statistical analyzes were performed using a statistical software 
package (SigmaPlot 12.5; Systat Software, Inc., San Jose, CA). Skin blood flow, %CVC, 
and skin temperature, Tskin, were both analyzed using a two-way repeated measures 
ANOVA comparing treatment (CON vs. NPLA vs. LNIO vs. LNAME) by time effects. 
When a main effect or interaction was found, a Tukey's posthoc analysis was performed to 
determine further differences. All data is shown as mean±SEM. For all tests, significance 






Skin temperature throughout the trial is shown in Fig 5a and decreased with skin 
cooling from baseline due to skin cooling (Baseline: 33.5±0.3 vs. Cooling: 27.9±0.6, 
24.3±0.6, 22.1±0.7, 20.6±0.7, 19.4±0.7, 18.6±0.7 °C; 5, 10, 15, 20, 25, 30 min cooling, 
respectively; p<0.001) and recovered towards baseline with passive rewarming when 
compared to 30 min cooling (30 and 60 Rewarming: 22.5±0.4, 24.1±0.3 °C, respectively; 
p<0.001), but still had not reached baseline levels even after 1 hr of rewarming. Skin 
temperature increased during passive rewarming and remained elevated during the 10 min 
following active warming (31±0.7, 30.6±0.4 °C, respectively; p<0.001). Skin temperatures 
were no different among the 4 treatments at any time point (p>0.05). 
There was no effect of drug treatment on CVC during the 34 ̊C baseline for CON, 
NPLA, or LNIO ( p>0.05), however, LNAME was found to be significantly lower than its 
predrug baseline (100±0 vs. 70±6 %, respectively; p<0.01). Skin blood flow during the 
~34°C baseline and throughout the cooling and reheating protocol is illustrated in Figure 
5b. Local cold water application resulted in a significant decrease from baseline %CVC in 
all trials (p < 0.001). However, there was no effect of the drug treatments across the 30 min 
of cryotherapy. During the passive rewarming period all treatments were not found to be 
significantly different across time or between treatments (Con: 13±1, LNAME: 15±2, 
NPLA: 13±2, LNIO: 15±1 % of baseline; p>0.05). Active heating significantly increased 
%CVC over the passive recovery phase for all treatments and in the 10 min following (60 
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min passive: 13±2 vs. 10 min active heating: 34±8, 10 min post active heating: 34±8 % of 
baseline; p<0.001). There was no effect of treatment during the active heating stage. 
Hysteresis loops were broken down into cooling, passive rewarming, and then 
active rewarming, separately, with a significant impact on phases of cooling, but not 
treatments and is shown in Figure 6. Posthoc analysis revealed passive skin cooling had a 
significantly different slope than both skin cooling and active warming (-0.55±1.34, 
4.31±1.23, 4.02±2.68 %CVC/°C, respectively; p<0.01), however, there was no difference 





Our primary finding is that when assessing the skin blood flow and temperature 
relationship that only active heating restored this relationship and was found to be 
augmented during passive rewarming. To our knowledge, we are not aware of any previous 
investigations that have shown with hysteresis loops, an impaired dilatory response with 
cryotherapy, which was restored by active heating. Local skin cooling that activates the 
Rho kinase pathway has multiple mechanisms for enhancing constriction and potentially 
leading to sustained vasoconstriction. We show a clear difference in the CVC/temperature 
response during passive recovery that only appears to be corrected with the application of 
hot water to the surface of the skin. This has significant implications for the use of 
cryotherapy in a clinical setting. 
Our assessment of the effects of NO on skin cooling was unable to identify a role 
for NO during cryotherapy. While previous investigations have identified a mechanism for 
Rho kinase to downregulate and inhibit NO(87), we were unable in our current 
investigation to show any action on NO. While LNAME was able to lower skin blood flow 
when compared to its predrug baseline, but not significantly different from any other drug 
treatments during the application of cryotherapy. Our heating protocol only increased skin 
blood flow from 13% to 34% it may be that within this range of vasoconstriction there is 
limited action of nitric oxide and may have yielded different results if skin was heated back 
to basal temperatures ~34°C. Hodges et al. showed in his investigation that during slow 
local cooling a portion of the vasoconstrictor response is driven by decreased NOS 
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activity(42). It may be that because of the rate of cooling with cryotherapy we were unable 
to show any action of nitric oxide. 
Some experimental considerations are that the heating protocol we used in this 
study was identical to the previous study #2. However, despite no differences in skin 
temperature at any point in the protocol, active heating led to a 30% lower CVC value for 
control treatments. Since several of the participants in this investigation were also in the 
previous investigation, it’s likely not driven by population differences. Perhaps, there is an 
effect of heat acclimation as these studies were done at different times of the year and 
perhaps have a lower blood flow response to our given protocol. 
In summary, we’ve shown that nitric oxide has no significant role in the 
vasoconstrictor response during a typical cryotherapy protocol and subsequent passive and 
active recovery phases. Additionally, it appears that the sustained vasoconstriction that 





TABLES AND FIGURES 
Figure 5. Temperature and blood flow responses to cryotherapy and the subsequent 
recovery 
 
Figure 5 - Panel A) Skin temperature during a typical cryotherapy protocol and the 
subsequent 1-hour recovery, 10 min active heating, and 20 minutes following. * denotes 
significantly different than baseline p<0.01. ** denotes significantly different than the end 
of the 60 min passive recovery period p<0.01. Panel B) † denotes significantly different 





Figure 6. Hysteresis loop during cryotherapy and the subsequent passive and active 
recovery 
 
Figure 6 – Hysteresis loops during a typical cryotherapy protocol and the subsequent 
passive and active rewarming phases. Passive rewarming was found to be significantly 
different from both active warming and active cooling (p<0.05).  
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Chapter 7: Review of the Literature 
BACKGROUND PHYSIOLOGY 
Historically investigations into thermoregulation have often led researchers down 
the path of heat stress. This is partly because our bodies have a finite limit for heat storage 
before an individual’s ability to perform work in strenuous environments is compromised. 
This was the primary reason for the Harvard Fatigue Lab arising from within the basement 
of the Harvard business school. At the time 14 workers had died and fallen due to heat 
stress, this required scientific inquiry as to improve work conditions and save lives. Bruce 
Dill and John Talbott were both sent to the Hoover dam with the focus at running 
biochemical and physiological studies on themselves and healthy volunteers. They 
concluded that the workers needed cooler sleeping quarters and the addition of copious 
amounts of salt in their meals(5), which improved work performance in the heat. 
Alternatively, in regards to cold stress, many investigations were directed at shielding the 
body from the low temperatures. Initially this aided the military as non-freezing cold 
injuries occur in civilian populations within manageable limits, but can reach epidemic 
proportions during war times(34).  
 Regulating cardiac output towards the skin is the primary method of regulating our 
internal core temperature with an effort to maintain thermoneutrality. Dramatic increases 
in core temperature can increase skin blood flow from almost zero in conditions of cold 
stress to as much as 8-10 L/min and becomes vital for maintaining a safe core 
temperature(50). The ability for blood to reduce the elevated thermal stress in the body lies 
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in the conductive and convective properties of heat dissipation in the skin. By dramatically 
increasing the blood flow to the skin and taking advantage of the evaporative properties of 
sweat, the rate of increase in core temperature can be minimized, significantly(15). 
Alternatively, during conditions of cold stress the blood flow can fall to near zero. The 
body attempts to maintain core temperature by inducing a state of profound 
vasoconstriction in the skin and periphery, which results in shunting of the blood towards 
the internal core, thus reducing the loss of heat in the extremities. The effect of tissue 
cooling can be further amplified by adding thermally conductive fluid to the surface of the 
skin enhancing the heat extraction over cold air. This is a benefit in regards to accelerating 
cooling with cryotherapy, but a serious medical concern with regards to hypothermia if the 
magnitude cooling becomes too much. 
 
VASOCONSTRICTION 
The mechanisms of vasoconstriction lie under the control of local factors and neural 
reflex mechanisms focused on optimizing the vasoconstrictor response. The neural 
components of the vasoconstrictor response were first theorized by Claude Bernard(13), a 
well-known physiologist, respected for his work on vasomotor nerves and for discovering 
glycogen(12). His conclusions laid the groundwork for later research, confirming that 
sympathetic neurons handled not only the resting vessel tone but also for the 
vasoconstriction observed during skin/body cooling(31, 36). The initial response to the 
exposure to cold stress, minimizing the convective heat loss, lies under the regulation of 
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local and reflex pathways. These systems can independently produce vasoconstriction, but 
cooperatively enhance vasoconstriction through multiple mechanisms. Local reflex 
vasoconstriction is mediated by perivascular sympathetic adrenergic nerves, which release 
norepinephrine (NE) and co-transmitters including neuropeptide Y (NPY) and is a graded 
response that can increase with intensity until a basement plateau is reached, where the 
vasculature becomes physically constrained(80, 81). Reflex vasoconstriction occurs when 
the skin temperature drops below 34°C due to convective or conductive heat loss to the 
environment(39) or by decreasing the core temperature, despite apparent changes in skin 
temperature(10). While skin cooling directly applies to the application of cryotherapy a 
reduction in core temperature without a change in mean skin temperatures is a rare 
occurrence, which most often presents under special clinical circumstances(14).  
With reflex vasoconstriction, the primary neurotransmitter, NE, is synthesized in 
the cell body of noradrenergic neurons from L-tyrosine, with a rate limiting enzyme 
tyrosine hydroxylase, and its essential cofactor tetrahydrobiopterin(BH4)(37, 83). While 
BH4 may be prone to oxidation and subsequently deactivated(69), NE synthesis is rarely 
abnormal in healthy young populations with healthy systemic redox states(59). Nerve 
blockade and/or the subcutaneous application of adrenergic receptor antagonists have 
revealed that approximately 60% of the overall vasoconstrictor response to sympathetic 
activity is attributed directly to NE(53, 80, 81). Isolation of different post-synaptic 
receptors by pharmacological blockade along with findings from in vivo models suggests 
that other transmitters released from the sympathetic neurons alongside NE also contribute 
to the overall tone. Both neuropeptide-y (NPY) and ATP have been identified as 
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cotransmitters with NE(38, 62), which are considered to be the only mediators of 
vasoconstriction released by adrenergic neurons. 
Also, in vitro models with direct stimulation of cutaneous vessels has provided 
evidence for Rho-kinase as the primary mediator in enhancing vasoconstrictor tone 
independent of adrenergic stimulation(27, 72). Local cooling of the skin stimulates the 
production of superoxides from the mitochondria, resulting in elevated reactive oxygen 
species (ROS), which acts as a stimulator of the Rho-kinase pathway(7). This pathway is 
responsible for modulating vasoconstrictor tone through two mechanisms: 1) inhibition of 
the myosin light chain phosphatase (MLCP), allowing for passive phosphorylation in the 
absence of calcium influx (enhanced constriction for any given stimulus); and 2) cAMP 
mediated translocation of α2c-adrenoceptors from the trans-Golgi to the surface of the cell. 
The latter mechanism results in a 5-fold increase in α2c-adrenoceptor density on the cell 
surface and thus enhances NE mediated vasoconstriction(6, 7, 16, 26, 48). These two 
mechanisms dramatically improve end-organ function within the vasculature in response 
to cooling as a way to enhance the neural reflex mechanisms(88). The Rho-kinase pathway 
also enhances vasoconstrictor tone in part by the down-regulation of nitric oxide synthase 
(NOS)(70, 79), which handles the formation of nitric oxide (NO) and vasodilation. The 
Rho-kinase and NOS pathways mediating vasoconstriction and vasodilation, respectively, 
are mutually inhibitory; cGMP-dependent protein kinase (PKG), involved in NO 
production, inhibits Rho-kinase activation, and Rho-kinase mediates phosphorylation of 
MLCP and Rho-kinase can downregulate endothelial NOS (eNOS)(70, 79). This interplay 
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between the two pathways is only partially understood, but it is likely significant as it 
pertains to cryotherapy treatment. 
During local cooling, similar to what would occur with cryotherapy, the initial 
response (0-10 min) is mediated primarily by reflex vasoconstriction via NE release which 
binds to α2 receptors(27) and is dependent upon the functionality of the sensory nerves(41). 
Treatment with bretylium tosylate, which prevents the post-synaptic release of 
neurotransmitters from the sympathetic neurons, results in a complete abolishment of 
vasoconstriction with local cooling during this time period with the outcome being a  slight 
vasodilatory response(53). If the cooling persists beyond 10 minutes, vasoconstriction 
persists through the addition of non-adrenergic mechanisms directed at reducing the 
dilatory function of the vessel by selective downregulation of eNOS(42, 51, 72) and 
enhancement of end-organ vasoconstriction by Rho-kinase mediated pathways(88)(as 
described above). However, these mechanisms appear to be slightly delayed and don’t 
seem to occur in the initial 10 min. Following 10-min vasoconstriction persists through the 
independent reflex neural mechanisms and local modulators. Additional mechanisms 
involved in vasoconstriction involves the reduced breakdown of NE (via MAO and COMT; 
enzyme breakdown), increased viscosity and aggregated platelets that release 5HT and 
thromboxane A2(85). While these processes take place in healthy young adults, advanced 
aging provides significant insight into the role of Rho-kinase as a local modulator to 
vasoconstriction. 
 Aged skin experiences impaired mechanisms of vasoconstriction, which often 
results in higher average blood flows during cold exposure and further compromising their 
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susceptibility to hypothermia(21, 56, 92). Much of the recent work has culminated in a 
model whereby sympathetic neurotransmission is decreased along with local intracellular 
signals suggesting more generalized age-associated vascular dysfunction(90). In 1977, KJ 
Collins and colleagues noted the higher incidence of hypothermia in the aged population 
which presented a growing medical concern(18). This elevated prevalence of ‘accidental 
hypothermia’ is not a function of falls, injuries, or illness as both fit, and unfit elderly 
people are prone to hypothermia. This rise in hypothermia is a natural hazard of advanced 
aging(18). Part of the impaired thermoregulatory function with aging has been attributed 
to lower neural stimulation with a given cold stress. Sympathetic nerve activity was 
recorded across young, middle ages, and elderly subjects, with the elderly population, 
experienced a 60% depression in bursts/min when compared to the other groups(35). Also 
reduced NE release in aged skin(92), it has been suggested that aged individuals also have 
reduced neurotransmitter synthesis(19, 24, 33). While in the young population 
vasoconstriction is mediated ~ 60% by NE and ~ 40% by co-transmitters, within the elderly 
population there is an almost a full dependency upon NE with a complete loss of NPY 
mediated vasoconstriction. Aged skin experiences blunted end-organ vascular function(57, 
91, 92). By direct administration of serial doses of NE and NPY, investigators have shown 
reduced sensitivity to both NE and NPY, but also a reduced maximal response(91, 92). 
Additionally, within aged rodent arterioles similar findings have been shown using ATP to 
assess end-organ vasoconstrictor function(57). In contrast to reflex vasoconstriction, local 
cold-induced vasoconstriction is also affected by aging as the magnitude of 
vasoconstriction from local mechanisms remains no different despite the reduced 
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adrenergic tone(89). This is partially due to a shift from an adrenergic control within the 
aged skin to having a larger dependence on the Rho-kinase pathway becoming the 
predominant contributor to constrictor tone(88). While the magnitude of local response to 
cooling does not change in the aged skin, the increased dependence on the Rho-kinase 
pathway in the aged skin may provide some insight into a host of vascular changes and 
diseases. Greater dependence on the Rho-kinase pathway results in an upregulation of the 
Rho-kinase pathways and is often associated with atherosclerosis, hypertension, vascular 
remodeling, erectile dysfunction, and diabetes(70). This may suggest that the change Rho-
kinase is a function of aging rather than disease.  
With normal healthy, young vessels the balance between Rho-kinase and NO 
(constrictor and dilator pathways) is slightly in favor of NO-mediated dilation. However, 
in the aged skin this is reversed to having a more predominate constrictor tone with a loss 
in endothelial dilation and enhancement in Rho-kinase mediated vasoconstrictor function. 
This is likely due to age and cold related increases in ROS production. Age-associated 
production of ROS and increased arginase activity both reduce the bioavailability of 
NO(43).  
Raynaud's Disease is a vascular disorder where tissues (ears, lips, fingers, nose, 
toes) undergo vasospasms in response to cold exposure, which exists as an abnormal 
version of the bodies normal physiological response. Raynaud's can be idiopathic in origin 
or can arise from mechanical, immunological, or chemical stressors within the blood 
vessels in the skin(70). The understanding of the underlying pathophysiology of Raynaud’s 
is incomplete; however, it has been suggested that the same mechanisms underlying local 
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vasoconstriction mediate the effects, but perhaps to a greater sensitivity(70). Because 
women of childbearing age and postmenopausal women taking just estrogen therapy reflect 
the largest incidence of Raynaud’s, estrogen has a likely role underlying the mechanisms(6, 
26). This may be because observations suggest estrogen is a strong stimulator of the α2 
species receptors and would enhance end-organ response. However, these were made in 
the absence of cold stimulation(26). This would perhaps open the door for potential 
therapies like statins, which inhibit Rho kinase, in at-risk populations(70). In regards to 
female aging, there appears to be no contribution of age is no longer a predictor of 
prevalence or severity. This is a contrast to men where age is considered to be a risk factor 
for the onset of the disease(26). 
VASODILATION 
Thermal control of body temperature is heavily dependent upon the compliance and 
vascular response to an increase in skin and/or core temperature, by increasing skin blood 
flow to values several fold higher over rest. The tremendous capacity for the skin to 
increase blood flow and optimize benefits from evaporative heat loss from sweat as well 
as convective cooling. During basal conditions the vasodilator systems aren’t under 
regulation, but with the input of thermal stress the vasodilation occurs initially via removal 
of tonic sympathetic mediated vasoconstriction and then later via cholinergic nerve 
transmission from sympathetic vasodilator nerves. The potential neurotransmitters 
involved in sympathetically mediated vasodilation include, nitric oxide and an unknown 
transmitter, potentially: histamine and neurokinin receptor activation(96), vasoactive 
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intestinal peptide (VIP)(9), calcitonin gene-related peptide (CGRP)(76) and substance 
P(96). 
Within healthy young skin, the thermoregulatory response during heat stress is to increase 
the activity of sympathetic cholinergic vasodilator nerves, which corelease acetylcholine, 
for sweating, and an unknown transmitter mediating the vasodilator response(64). Direct 
warming of the skin causes the dilation of local vascular beds to the degree and speed of 
local warming(8, 40). When local heating results in a rapid increase in skin temperature to 
42°C and maintained for a period, local skin blood flow increases to its maximum 
level(49). Post-synaptic blockade of the muscarinic receptor attenuates the initial rise in 
skin blood flow, but not plateau, while completely abolishing the cutaneous sweat 
response. The presynaptic blockade, removing the ability for the cholinergic nerves to 
release any neurotransmitters completely abolishes the sweating and vasodilatory 
response(54). This suggests that the corelease of acetylcholine mediates part of the initial 
rise in blood flow and not just sweat response, but is unable to change the vessels maximal 
dilatory capacity. Isolation of the specific neurotransmitter responsible for the dilatory 
response is highly complex and remains elusive. Many of the proposed co-transmitters all 
play some role in the dilatory response and wholly may overlap becoming redundant. This 
is because acetylcholine(78), VIP(95), and substance P(96) all contribute to the 
vasodilatory pathway, stimulating NO release. Many of these chemicals contribute to NO-
dependent vasodilation during different phases of the rise in skin blood flow. For example, 
disruption of the cholinergic component in active vasodilation is unable to change the final 
plateau phase(77).  
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Regardless of which, co-transmitter is the primary mediator of active vasodilation, 
nitric oxide is an essential component of this mechanism. Augmentation of (NOS) can 
handle 30-40% of the total maximal vasodilator response in healthy intact skin. In 
conjunction with NO, cyclooxygenase (COX)-dependent pathways also contribute to 
active vasodilation(63). Both NO and COX mediate dilation, but to what extent the two 
pathways are interactive has not yet been elucidated. Selective blockade of both pathways 
would suggest that their effects are additive in nature and not uniquely dependent upon 
each other. COX can be activated by the acetylcholine mechanism and mediates both early 
and late formation of prostanoids contributing to active vasodilation(44). The late release 
of prostanoids during active vasodilation during higher flow rates occurs through the 
stimulation of sheer stress on the endothelial layer, further enhancing the dilatory 
mechanisms(63). Furthermore, COX can alternatively be stimulated by NK1 receptor 
activation, increasing the calcium concentration in endothelial cells, stimulating the NOS 
and COX pathways(96).  
While many of the mechanisms underlying these impaired neurotransmission and 
loss of NPY function have not fully been elucidated recent research has identified that de 
novo synthesis of BH4 and recycling pathways are vulnerable to oxidation from ROS. It 
has been established that aging is associated with elevated oxidation due to a shift in the 
redox state of the cell towards producing more reactive oxygen species(25). It is thought 
that this oxidation of BH4 explains the decreased adrenergic function in aged skin and the 
reduced bioavailability of BH4(23, 58). In aging models supplementation with BH4, 
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reverses the age-associated vasodilatory dysfunction by increasing BH4 bioavailability in 
the vascular endothelium(23, 28). 
 
CRYOTHERAPY 
Cryotherapy is the use of cold water or ice to reduce the temperature of the skin, 
surrounding tissues, and often applied to aid in tissue recovery. The known benefits of 
applying cold water to the body date back to the ancient Greeks when it was used to reduce 
an inflammatory response to injury or trauma. Historical methods of cryotherapy involved 
the use of snow, ice or water, but in more recent years more advanced methods have 
allowed for more accessible methods of reducing pain and inflammation. Commercially 
available devices can now be fitted with water perfused bladders, connected with a water 
pump and water circulated to allow for the benefit of cryotherapy, with greater ease. This 
in conjunction with the known benefits of cryotherapy has led to an increase in availability 
and comfort of treatment at home. It is been used to aid in the recovery following a range 
of traumas, post-surgical recovery, and a multitude of other clinical environments. For 
example, cryotherapy is shown to have an additive response in conjunction with narcotics 
following surgery by providing added analgesic effects to reduce pain. However, despite 
the high prevalence and knowledge of the benefits of cold application to the skin, much of 
the underlying mechanisms mediating the benefits are only partially understood. Trauma 
and tissue injury are heterogeneous in nature that include different tissues with different 
responses, with can fluctuate in the magnitude of injury, as well as kinetically over time. 
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This has led to the popular knowledge of cryotherapy based upon the conclusions from 
clinical and empirical findings leaving much of the population unable to fully grasp the 
potentially deleterious effects of cryotherapy. While acute cooling can be very useful and 
can significantly reduce swelling, inflammation, and pain; prolonged cryotherapy has the 
potential to amplify tissue damage by impairing the cellular activity and vascular responses 
resulting in necrosis and cell death. With the use of cold compress, as the length of time 
and magnitude of cooling increase in magnitude or length the potential for injury to go up.  
Cryotherapy has become popularized due to its three main tissue responses; 
analgesia, depression of metabolism, and its vascular responses. Additionally, the 
depression of nerve temperature results in decreased nerve conduction until it is ultimately 
blunted altogether(2) and may prevent muscle spasms generating secondary ischemia 
injury or perhaps by reducing sensory nerve action(1). In regards to the injury, some 
investigators consider the effects of cold on metabolism to be the most important at 
reducing secondary injury from trauma(1, 65). Following most tissue injuries the cellular 
damage results in an inflammatory response, which causes swelling and tissue ischemia 
over 24 hours following the initial insult(52). Mclean clearly describes that the decreases 
in enzymatic activity that occurs with cryotherapy explains why tissue injury is attenuated 
by reducing the ischemic stress and lowering the cellular oxygen demand(65). With the 
initial insult causing cell damage, increased inflammatory mediators triggering elevated 
capillary permeability, increasing the edema. Furthermore, the release of intracellular 
proteins from damaged cells elevates the osmotic pressure within the extracellular space 
pulling water from the circulation into the site of injury. This local increase in fluid build-
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up results in exponentially increasing the diffusion distance for oxygen generating hypoxic 
pockets within tissues. The following inflammation induced ischemia can impair tissue 
recovery and long-term improvements following an injury. 
This reinforces the importance of understanding cryotherapies robust anti-
inflammatory response when involved in the initial treatment of acute injuries. Direct cold 
application to the skin has previously shown that the permeability, magnitude of 
inflammation or swelling, and cellular response changes directly based on the tissue 
temperature(46). This supports the notion that RICE, i.e. rest, ice, compression, and 
elevation, should be an essential and immediate response to injury. This is an effective 
treatment and a safe way of limiting the extent of the injury, reducing the inflammatory 
stress as well as offering effective pain management(22). Cryotherapy is often the initial 
treatment following a sprain, tear, strains, or other inflammatory processes. This is partly 
due to the fact that cold application has been previously shown to reduce the inflammatory 
response with experimentally induced ligament injuries(30, 46). Cryotherapy results in 
increased permeability of the lymph vessels and can often lead to elevated swelling 
following cryotherapy(71). This has led to some controversy due to the fact that some 
instances of cryotherapy use has also been associated with increased inflammation as 
well(46). This may partially be explained that clinically the formation of edema following 
cryotherapy hasn’t been recreated due to the elevation and compression that typically 
follows or is associated with cryotherapy. Precautions clinically involve monitoring time, 
length of cooling, and magnitude of tissue cooling for safety. While the exact temperature 
where cryotherapy becomes deleterious is not known temperatures around 15°C, where the 
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permeability of the lymph vessels increases could result in adverse inflammatory responses 
enhancing swelling(67). Precautions should be taken with the use of cold temperatures and 
may result in damaging effects. Additionally, a lesser known phenomena with cryotherapy 
application is that following use, passive warming of the tissue fails to stimulate the return 
of blood flow. The tissue can’t remove the underlying constrictor tone, the temperature 
continues to rise, enzyme activity and oxygen demand return, but blood flow remains 
blunted (~70% reduced). If this occurs following an injury with inflammatory induced 
ischemic stress, it may exacerbate the ischemic injury and result in greater cell/tissue loss. 
Understanding the vascular effects of cold application happen to be more complex 
and involves neural, end target receptor changes, smooth muscle, platelet and endothelial 
mechanisms. The initial phase of cooling is often the most rapid and causes reflex 
vasoconstriction from sympathetic neurons decreasing local blood flow and is followed by 
increased density of α2 receptors enhancing end-organ function. The thermal effects reduce 
the metabolic activity of noradrenaline metabolizing enzymes (MAO and COMT), the 
increased blood viscosity due to constriction and aggregated activated platelets, releasing 






Chapter 8: General Discussion and Future Directions 
 Cryotherapy treatment is perhaps one of the most often utilized therapies in the 
United States. However, despite how commonly used, there are much fewer studies 
verifying and supporting its use and even fewer detailing its shortcomings and potential 
detrimental effects. While these studies haven’t changed the importance of cryotherapy 
they’ve introduced a better understanding towards the possible ramifications of 
unsupervised or inappropriate cryotherapy treatment. Specifically, these studies highlight 
the significance of reheating tissue temperatures following “treatment.” 
 This is based on our findings that show impaired blood flow/temperature 
responses for 2 hrs following cryotherapy and was only corrected by inhibition of Rho 
kinase or by actively heating the treated skin. This impaired blood flow/temperature 
response, we believe, is a direct result of the action of Rho kinase by enhancing 
vasoconstriction. Based on our findings we feel that there is not enough evidence to 
suggest that the impairment of nitric oxide function contributes to the manifestation of a 
profound and sustained vasoconstriction with cryotherapy use. This would propose the 
action of Rho kinase is primarily due to its enhanced end-organ sensitivity(70) and 
function(6). 
 Of unique interest in our investigations was the finding that despite a similar 
protocol and similar temperatures reached in the skin, blood flow responses to cold were 
augmented. While there isn’t substantial evidence to suggest that the microcirculation can 
exhibit changes in vasoconstrictor tone with heat acclimation, there is little else that could 
explain such large differences in %CVC despite similar subjects and protocol. There have 
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been investigations showing the microvascular changes that occur with heat acclimation 
in trained cyclists(61), but a comparison of results is difficult due to their assessment 
during local heating rather than cooling. However, our findings would still support the 
notion of heat acclimation by having lower %CVC for a given temperature. 
 The future focus of research should be to understand better the significance of the 
Rho kinase pathway. It appears after these investigations that the Rho kinase pathway is 
the ultimate contributor to sustained vasoconstriction and as such a potent modulator of 
vasoconstriction important in the development of non-freezing cold injuries. Independent 
of cryotherapy the significance of understanding Rho kinase extends towards 
cardiovascular disease as a whole due to its effects on vascular tone and proliferation of 
vascular smooth muscle cells(3, 75). Furthermore, due to the fact that as adrenergic 
activity, neurotransmitter release, and sensitivity decrease with age, resulting in a greater 
reliance on the action of Rho kinase, the significance upon aging should be investigated 
more significantly(89, 90). Due to the enhanced activity of Rho kinase and its ability to 
induce profound and sustained vasoconstriction when activated, it lends the aged 
population at greater risk for all potential deleterious effects of cryotherapy or vascular 
health. It has been suggested that because of the greater dependence upon Rho kinase 
with aging that there’s a shift from a state of youthful vasodilatory action towards an 
aged vasoconstrictor tone(59). This may partially contribute with the age-associated 
development of cardiovascular disease. 
 Our investigations illustrated, to some degree, that nitric oxide plays a no role in a 
typical cryotherapy protocol. This would suggest that much of what occurs during 
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cryotherapy is vasoconstriction dependent rather than a withdrawal of dilatory tone, 
within our population and model. This would suggest that much of the action of Rho 
kinase is mediated by heightened sensitivity to norepinephrine and increased 
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